FDA Inspection 1200223 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on March 16, 2023 in West Palm Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 16, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- West Palm Beach, FL (United States)